Aubrai by Bio Prediction

About Aubrai by Bio (AUBRAI)

Aubrai is a novel decentralized AI agent token focused on longevity science, co-developed by VitaDAO and BIO with backing from Dr. Aubrey de Grey's research. The token operates at a $4.04M market cap with 2M total supply and represents a unique intersection of AI, biotech, and decentralized science. However, the token exhibits extreme holder concentration (88% in top 10) and virtually no retail participation, creating significant structural risks despite its innovative positioning and institutional credibility.

Current price: $2.61

Market cap: $5.22M

Liquidity: $88.58K

Holders: 2.8K

Aubrai by Bio Price Prediction

With 88% of supply concentrated in the top 10 holders and only 0.28% holder growth in 24 hours, short-term price action is likely to remain range-bound with low volatility. The token shows minimal retail participation (0% of supply), suggesting limited organic buying pressure. Recent holder growth of 1.5% over 7 days indicates gradual but modest accumulation interest.

Medium-term outlook is cautiously bullish if RMR2 project milestones are achieved and community adoption increases. The token's unique positioning in longevity science and AI agents provides differentiation, but success heavily depends on scientific validation and ecosystem expansion. Holder growth of 4.9% over 30 days suggests emerging interest, though concentration risk remains the primary constraint.